안내 임플란트 시장 규모, 점유율, 성장 및 세계 업계 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of ocular implants Market

The global ocular implants market size was valued at USD 16.80 billion in 2025. The market is projected to grow from USD 17.96 billion in 2026 to USD 30.64 billion by 2034, registering a CAGR of 6.90% during 2026-2034. North America dominated the global ocular implants market with a 34.25% market share in 2025. Increasing awareness of ocular diseases, improved ophthalmic diagnostics, and greater accessibility to information about treatment options are supporting the adoption of advanced ocular implants.

The market includes intraocular lenses, glaucoma implants, ocular prostheses, corneal implants, and other implantable ophthalmic devices. Rising cataract and glaucoma prevalence, technological innovation, and increasing access to ophthalmic surgery are expected to strengthen market growth.

Market Trends

A significant ocular implants market trend is the increasing adoption of technologically advanced ocular prostheses. Improvements in digital technology are enabling more precise and faster construction of artificial eyes that closely replicate the appearance of natural eyes. Glass, acrylic, and scleral-shell prostheses are increasingly being developed to address both functional and aesthetic requirements.

Another important trend is the growing adoption of microinvasive glaucoma surgery devices and advanced intraocular lenses. Increasing patient awareness and the availability of sophisticated ophthalmic procedures are encouraging patients to seek modern implant-based treatments.

Market Drivers

Increasing Prevalence of Cataract and Glaucoma:

The rising burden of cataract, glaucoma, refractive errors, and other ocular disorders, particularly among the aging population, is driving demand for ocular implants. Cataract prevalence is particularly significant across Asia, including China, India, and Japan, creating substantial opportunities for intraocular lens manufacturers.

Technological Advancements:

Innovations in bionic vision systems, microinvasive glaucoma devices, advanced intraocular lenses, and corneal implants are improving treatment options. Emerging technologies such as wireless sub-retinal implants are also creating new possibilities for patients with severe vision loss.

Market Restraints and Challenges

Stringent Regulatory Approvals and Product Recalls:

Ocular implants require rigorous regulatory evaluation because complications can directly affect vision and eye health. Lengthy approval procedures can delay product commercialization. Product recalls and safety concerns can also reduce patient and physician confidence. Limited access to advanced ophthalmic treatment in underdeveloped countries remains another important challenge.

Segmentation Analysis

By Product Type:

The market is segmented into intraocular lenses, glaucoma implants, ocular prosthesis, corneal implants, and others. Intraocular lenses dominated the market with a 66.6% share in 2025, supported by the increasing prevalence of cataracts, technological advancements, and wider accessibility. Glaucoma implants are also expected to experience healthy growth due to increasing adoption of microinvasive glaucoma surgery devices.

By End User:

The market is categorized into hospitals, ophthalmic clinics, and others. Hospitals held the dominant market position, supported by the increasing number of ophthalmic surgeries and availability of advanced healthcare infrastructure. The hospital segment is projected to generate USD 3,767.6 million in revenue by 2025.

Regional Analysis

North America dominated the global market with a 34.25% share in 2025, supported by high adoption of advanced ocular implants, favorable reimbursement policies, established healthcare infrastructure, and strong presence of leading market players.

Europe is expected to maintain steady growth, with the source indicating a 5.3% CAGR during the forecast period. Increasing adoption of technologically advanced ophthalmic devices in countries such as Germany, France, and the U.K. is supporting regional demand.

Asia Pacific is anticipated to register the fastest growth due to the increasing geriatric population, high prevalence of cataracts and glaucoma, and improving accessibility to ophthalmic treatments. Japan's ocular implants market is expected to reach USD 442.1 million by 2025, while India is projected to register a 7.70% CAGR during the forecast period.

Latin America and the Middle East & Africa currently account for comparatively smaller shares but offer future opportunities as healthcare infrastructure and treatment accessibility improve.

Key Industry Players

Major companies in the ocular implants market include Alcon, Johnson and Johnson Services, Inc., Bausch & Lomb Incorporated, ZEISS International, STAAR SURGICAL, Hoya Corporation, Glaukos, Second Sight, and Allergan. Alcon and Johnson & Johnson maintain strong competitive positions through their extensive intraocular lens portfolios and ophthalmic device offerings.

Recent Industry Developments

In January 2018, Glaukos submitted an IDE application to the U.S. FDA for its iStent infinite glaucoma treatment device. In March 2019, Novartis announced the spin-off of ownership of Alcon, marking its exit from the eye-care industry.

Future Outlook

The ocular implants market outlook remains positive through 2034. The market is expected to expand from USD 16.80 billion in 2025 to USD 17.96 billion in 2026 and USD 30.64 billion by 2034. Increasing cataract and glaucoma prevalence, rising awareness, technological innovation, and growing ophthalmic surgery volumes are expected to create sustained opportunities. Asia Pacific is likely to remain an important growth region, while North America continues to benefit from advanced healthcare infrastructure and strong adoption of innovative devices.

Conclusion

The global ocular implants market is positioned for steady expansion as the prevalence of eye disorders increases and patients gain greater access to advanced ophthalmic treatments. Intraocular lenses remain the dominant product category, while glaucoma implants, ocular prostheses, and emerging technologies are creating additional opportunities. Although stringent regulations, product safety concerns, and limited accessibility in developing markets remain challenges, continued technological advancements and increasing demand for effective vision-restoration solutions are expected to support market growth through 2034.

Unit Value (USD billion)

Segmentation By Product Type

• Intraocular Lens
• Glaucoma Implants
• Ocular Prostheses
• Corneal Implants and Others

By End-user

• Hospitals
• Ophthalmic Clinics
• Others

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Epidemiology of Key Ocular Disorder - for Key Countries
• 4.2. Key Industry Developments - Mergers, Acquisitions, and Partnerships
• 4.3. Overview of Regulatory Scenario in Key Countries/ Regions
• 4.4. Introduction of New Products/ Approvals in Ocular Implant Industry
• 4.5. Snapshot of Global Ophthalmic Surgery Devices Market

5. Global Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product Type
  • 5.2.1. Intraocular Lens
  • 5.2.2. Glaucoma Implants
  • 5.2.3. Ocular Prostheses
  • 5.2.4. Corneal Implants and Others
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospitals
  • 5.3.2. Ophthalmic Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Country
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis - By Product Type
  • 6.2.1. Intraocular Lens
  • 6.2.2. Glaucoma Implants
  • 6.2.3. Ocular Prostheses
  • 6.2.4. Corneal Implants and Others
• 6.3. Market Analysis - By End-user
  • 6.3.1. Hospitals
  • 6.3.2. Ophthalmic Clinics
  • 6.3.3. Others
• 6.4. Market Analysis - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis - By Product Type
  • 7.2.1. Intraocular Lens
  • 7.2.2. Glaucoma Implants
  • 7.2.3. Ocular Prostheses
  • 7.2.4. Corneal Implants and Others
• 7.3. Market Analysis - By End-user
  • 7.3.1. Hospitals
  • 7.3.2. Ophthalmic Clinics
  • 7.3.3. Others
• 7.4. Market Analysis - By Country
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis - By Product Type
  • 8.2.1. Intraocular Lens
  • 8.2.2. Glaucoma Implants
  • 8.2.3. Ocular Prostheses
  • 8.2.4. Corneal Implants and Others
• 8.3. Market Analysis - By End-user
  • 8.3.1. Hospitals
  • 8.3.2. Ophthalmic Clinics
  • 8.3.3. Others
• 8.4. Market Analysis - By Country
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis - By Product Type
  • 9.2.1. Intraocular Lens
  • 9.2.2. Glaucoma Implants
  • 9.2.3. Ocular Prostheses
  • 9.2.4. Corneal Implants and Others
• 9.3. Market Analysis - By End-user
  • 9.3.1. Hospitals
  • 9.3.2. Ophthalmic Clinics
  • 9.3.3. Others
• 9.4. Market Analysis - By Country
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis - By Product Type
  • 10.2.1. Intraocular Lens
  • 10.2.2. Glaucoma Implants
  • 10.2.3. Ocular Prostheses
  • 10.2.4. Corneal Implants and Others
• 10.3. Market Analysis - By End-user
  • 10.3.1. Hospitals
  • 10.3.2. Ophthalmic Clinics
  • 10.3.3. Others
• 10.4. Market Analysis - By Country
  • 10.4.1. GCC Countries
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Competition Dashboard
• 11.4. Comparative Analysis - Major Players
• 11.5. Company Profiles
  • 11.5.1. Alcon
    • 11.5.1.1. Overview,
    • 11.5.1.2. Products & services,
    • 11.5.1.3. SWOT analysis,
    • 11.5.1.4. Recent developments,
    • 11.5.1.5. strategies,
    • 11.5.1.6. financials (based on availability)
  • 11.5.2. Johnson and Johnson Services, Inc.
    • 11.5.2.1. Overview,
    • 11.5.2.2. Products & services,
    • 11.5.2.3. SWOT analysis,
    • 11.5.2.4. Recent developments,
    • 11.5.2.5. strategies,
    • 11.5.2.6. financials (based on availability)
  • 11.5.3. Bausch & Lomb Incorporated
    • 11.5.3.1. Overview,
    • 11.5.3.2. Products & services,
    • 11.5.3.3. SWOT analysis,
    • 11.5.3.4. Recent developments,
    • 11.5.3.5. strategies,
    • 11.5.3.6. financials (based on availability)
  • 11.5.4. ZEISS International
    • 11.5.4.1. Overview,
    • 11.5.4.2. Products & services,
    • 11.5.4.3. SWOT analysis,
    • 11.5.4.4. Recent developments,
    • 11.5.4.5. strategies,
    • 11.5.4.6. financials (based on availability)
  • 11.5.5. STAAR SURGICAL
    • 11.5.5.1. Overview,
    • 11.5.5.2. Products & services,
    • 11.5.5.3. SWOT analysis,
    • 11.5.5.4. Recent developments,
    • 11.5.5.5. strategies,
    • 11.5.5.6. financials (based on availability)
  • 11.5.6. Hoya Corporation
    • 11.5.6.1. Overview,
    • 11.5.6.2. Products & services,
    • 11.5.6.3. SWOT analysis,
    • 11.5.6.4. Recent developments,
    • 11.5.6.5. strategies,
    • 11.5.6.6. financials (based on availability)
  • 11.5.7. Glaukos
    • 11.5.7.1. Overview,
    • 11.5.7.2. Products & services,
    • 11.5.7.3. SWOT analysis,
    • 11.5.7.4. Recent developments,
    • 11.5.7.5. strategies,
    • 11.5.7.6. financials (based on availability)
  • 11.5.8. Second Sight
    • 11.5.8.1. Overview,
    • 11.5.8.2. Products & services,
    • 11.5.8.3. SWOT analysis,
    • 11.5.8.4. Recent developments,
    • 11.5.8.5. strategies,
    • 11.5.8.6. financials (based on availability)
  • 11.5.9. Allergan
    • 11.5.9.1. Overview,
    • 11.5.9.2. Products & services,
    • 11.5.9.3. SWOT analysis,
    • 11.5.9.4. Recent developments,
    • 11.5.9.5. strategies,
    • 11.5.9.6. financials (based on availability)
  • 11.5.10. Other Prominent Players
    • 11.5.10.1. Overview,
    • 11.5.10.2. Products & services,
    • 11.5.10.3. SWOT analysis,
    • 11.5.10.4. Recent developments,
    • 11.5.10.5. strategies,
    • 11.5.10.6. financials (based on availability)

12. Strategic Recommendations